| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10744909 | Parkinsonism & Related Disorders | 2015 | 5 Pages |
Abstract
The reduced prevalence of current smokers among PD subjects as compared to healthy controls is consistent with previous findings, suggesting a possible neuroprotective effect of smoking. However, it could be due, at least in part, to the increased prevalence of former smokers among PD patients, that were more prone to quit smoking as compared to healthy controls. We suggest that smoking cessation could be an early preclinical condition occurring in PD.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Marcello Moccia, Roberto Erro, Marina Picillo, Edoardo Vassallo, Carmine Vitale, Katia Longo, Marianna Amboni, Gabriella Santangelo, Raffaele Palladino, Antonio Nardone, Maria Triassi, Paolo Barone, Maria Teresa Pellecchia,